Bacterial infections claim millions of lives yearly around the world. While some treatments exist, bacterial drug resistance remains a problem that contributes to the persistence and spread of bacterial diseases. Synthetic and naturally occurring organic compounds may hold solutions for identifying novel cellular targets that can be exploited to fight drug-resistant bacteria. In this webinar, Paul Hergenrother will discuss how his team discovered an antibiotic that targets multidrug-resistant bacteria in mouse models of acute pneumonia and septicemia while preserving the gut microbiome.
Topics to be covered
- Developing a selective antibiotic for multidrug-resistant gram-negative bacteria
- Generating an antibiotic that is selective for pathogenic bacteria over commensal bacteria
Friday, August 23rd, 2024 | 1:00 PM - 2:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speaker
Paul Hergenrother, PhD
Professor, University of Illinois at Urbana-Champaign
Chief Scientific Officer, Vanquish Oncology